共 121 条
[1]
PHENYTOIN CUMULATION KINETICS
[J].
CLINICAL PHARMACOLOGY & THERAPEUTICS,
1979, 26 (04)
:445-448
ALLEN, JP
;
LUDDEN, TM
;
BURROW, SR
;
CLEMENTI, WA
;
STAVCHANSKY, SA
.
[2]
ANAVEKAR SN, 1978, CLIN PHARMACOL THER, V24, P629
[3]
EVALUATION OF AN ULTRAFILTRATION FLUORESCENCE POLARIZATION IMMUNOASSAY FOR MONITORING UNBOUND PHENYTOIN
[J].
THERAPEUTIC DRUG MONITORING,
1984, 6 (01)
:117-120
ARGYLE, JC
;
KINNIBURGH, DW
;
COSTA, R
;
JENNISON, T
.
[4]
IDENTIFYING PATIENTS WHO MIGHT BENEFIT FROM FREE PHENYTOIN MONITORING
[J].
THERAPEUTIC DRUG MONITORING,
1987, 9 (02)
:134-138
BAIRDLAMBERT, J
;
MANGLICK, MP
;
WALL, M
;
BUCHANAN, N
.
[5]
2-FOLD INTERINDIVIDUAL VARIATION IN PLASMA-PROTEIN BINDING OF PHENYTOIN IN PATIENTS WITH EPILEPSY
[J].
CLINICAL PHARMACOKINETICS,
1976, 1 (06)
:444-452
BARTH, N
;
ALVAN, G
;
BORGA, O
;
SJOQVIST, F
.
[6]
PHENYTOIN MICHAELIS-MENTEN PHARMACOKINETICS IN CAUCASIAN PEDIATRIC-PATIENTS
[J].
CLINICAL PHARMACOKINETICS,
1983, 8 (06)
:545-549
BAUER, LA
;
BLOUIN, RA
.
[7]
AGE AND PHENYTOIN KINETICS IN ADULT EPILEPTICS
[J].
CLINICAL PHARMACOLOGY & THERAPEUTICS,
1982, 31 (03)
:301-304
BAUER, LA
;
BLOUIN, RA
.
[8]
COMPUTATION OF THE EXPLICIT SOLUTION TO THE MICHAELIS-MENTEN EQUATION
[J].
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS,
1983, 11 (06)
:641-657
BEAL, SL
.
[9]
ANTI-CONVULSANT SERUM LEVELS ARE USEFUL ONLY IF THE PHYSICIAN APPROPRIATELY USES THEM - AN ASSESSMENT OF THE IMPACT OF PROVIDING SERUM LEVEL DATA TO PHYSICIANS
[J].
EPILEPSIA,
1983, 24 (03)
:330-335
BEARDSLEY, RS
;
FREEMAN, JM
;
APPEL, FA
.
[10]
BECK DE, 1987, CLIN PHARMACY, V6, P888